NCT03848039View on ClinicalTrials.gov

Impact on Disease Relapse of HPV Vaccination in Women Treated With LEEP for Cervical Intraepithelial Neoplasia. HOPE9

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

1,220

Participants

Timeline

Start Date

December 31, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

May 31, 2028

Conditions
Cervical Intraepithelial Neoplasia
Interventions
BIOLOGICAL

Gardasil-9

administration by intramuscular injection of the 9-valent HPV vaccine according to a 3-dose vaccination schedule (0, 2, 6 months).

DRUG

Placebo

administration by intramuscular injection of the placebo according to vaccination schedule of the 9-valent HPV vaccine (0, 2, 6 months)

All Listed Sponsors
lead

Alessandro Ghelardi

OTHER